Shaji R. Velayudhan

Vellore, TN, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

UTF1 Expression is Important for the Generation and Maintenance of Human iPSCs.

UTF1 Expression is Important for the Generation and Maintenance of Human iPSCs.

Journal: Stem cell reviews and reports

Published: December 21, 2024

Editing of homologous globin genes by nickase-deficient base editor mitigates large intergenic deletions in HSPCs.

Editing of homologous globin genes by nickase-deficient base editor mitigates large intergenic deletions in HSPCs.

Journal: Molecular therapy. Nucleic acids

Published: December 02, 2023

Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.

Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.

Journal: Cellular signalling

Published: November 06, 2023

Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.

Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.

Journal: Annals of hematology

Published: November 04, 2023

Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.

Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.

Journal: Frontiers in molecular biosciences

Published: September 16, 2023

Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].

Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].

Journal: Leukemia research

Published: May 31, 2023

Establishment and characterization of CSCRi006-A: an induced pluripotent stem cell line generated from a patient with Diamond-Blackfan Anemia (DBA) carrying ribosomal protein S19 (RPS19) mutation.

Establishment and characterization of CSCRi006-A: an induced pluripotent stem cell line generated from a patient with Diamond-Blackfan Anemia (DBA) carrying ribosomal protein S19 (RPS19) mutation.

Journal: Human cell

Published: May 03, 2023

Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.

Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 28, 2023

Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors.

Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors.

Journal: Molecular therapy. Nucleic acids

Published: April 28, 2023

Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression.

Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression.

Journal: Scientific reports

Published: April 22, 2023

Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.

Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.

Journal: Stem cell research

Published: March 24, 2023

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo.

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo.

Journal: Frontiers in pharmacology

Published: March 15, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026